Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Hanks SM"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Choi VW; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Cambridge, Massachusetts, USA., Bigelow CE; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Cambridge, Massachusetts, USA., McGee TL; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Cambridge, Massachusetts, USA., Gujar AN; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Cambridge, Massachusetts, USA., Li H; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Cambridge, Massachusetts, USA., Hanks SM; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Cambridge, Massachusetts, USA., Vrouvlianis J; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Cambridge, Massachusetts, USA., Maker M; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Cambridge, Massachusetts, USA., Leehy B; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Cambridge, Massachusetts, USA., Zhang Y; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Cambridge, Massachusetts, USA., Aranda J; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Cambridge, Massachusetts, USA., Bounoutas G; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Cambridge, Massachusetts, USA., Demirs JT; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Cambridge, Massachusetts, USA., Yang J; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Cambridge, Massachusetts, USA., Ornberg R; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Fort Worth, Texas, USA., Wang Y; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Fort Worth, Texas, USA., Martin W; Preclinical Safety, Alcon , Fort Worth, Texas, USA., Stout KR; Preclinical Safety, Alcon , Fort Worth, Texas, USA., Argentieri G; Preclinical Safety, Novartis Institutes for BioMedical Research , East Hanover, New Jersey, USA., Grosenstein P; Preclinical Safety, Novartis Institutes for BioMedical Research , East Hanover, New Jersey, USA., Diaz D; Preclinical Safety, Novartis Institutes for BioMedical Research , East Hanover, New Jersey, USA., Turner O; Preclinical Safety, Novartis Institutes for BioMedical Research , East Hanover, New Jersey, USA., Jaffee BD; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Cambridge, Massachusetts, USA., Police SR; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Cambridge, Massachusetts, USA., Dryja TP; Ophthalmology Disease Area, Novartis Institutes for BioMedical Research , Cambridge, Massachusetts, USA.
Publikováno v:
Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2015 Jul 08; Vol. 2, pp. 15022. Date of Electronic Publication: 2015 Jul 08 (Print Publication: 2015).
Autor:
Poor SH; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States., Qiu Y; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States., Fassbender ES; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States., Shen S; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States., Woolfenden A; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States., Delpero A; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States., Kim Y; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States., Buchanan N; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States., Gebuhr TC; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States., Hanks SM; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States., Meredith EL; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States., Jaffee BD; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States., Dryja TP; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States.
Publikováno v:
Investigative ophthalmology & visual science [Invest Ophthalmol Vis Sci] 2014 Sep 09; Vol. 55 (10), pp. 6525-34. Date of Electronic Publication: 2014 Sep 09.